FDA Approves First Nasal Spray for Anaphylaxis Treatment
FDA approves Neffy, the first epinephrine nasal spray for anaphylaxis treatment, offering a needle-free alternative to injections with comparable efficacy for emergency care.

Keep reading
FDA approves Neffy, the first epinephrine nasal spray for anaphylaxis treatment, offering a needle-free alternative to injections with comparable efficacy for emergency care.

Keep reading